Validation of Serum Metabolite Differences in Patients With Gallstones and Gallbladder Cancer

Completed

Conditions studied: Gallstone Disease, Gallbladder Malignant Neoplasm

In brief

We have observed that the serum levels of certain metabolites differ between Chilean patients with gallbladder cancer and those with gallstone disease. Based on these discovery results, we selected ten candidate metabolites based on the smallest p-values among metabolites exhibiting a fold-change greater than 1.5. The aim of the present study is to validate these ten differential metabolite levels in an independent cohort of Chilean patients with gallbladder cancer and gallstone disease, and to assess the transferability of these findings to other patient populations.

Key facts

Study ID
NCT07744477
Run by
Centre Paul Strauss
People needed
230
Starts
2019-12-01
Expected to finish
2026-01-31
Last updated by the study team
2026-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.